Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Caesarstone
CSTE
$69.5M
| $1.35M | ﹤0.01% |
+90,164
| New | +$1.35M |
|
|
LOAN
2552
Manhattan Bridge Capital
LOAN
$48M
| $1.35M | ﹤0.01% |
211,702
-26,400
| -11% | -$162K |
|
|
GVP
2553
DELISTED
GSE Systems, Inc.
GVP
| $1.35M | ﹤0.01% |
57,916
+496
| +0.9% | +$12.2K |
|
2554
InfuSystem Holdings
INFU
$197M
| $1.35M | ﹤0.01% |
314,722
+830
| +0.3% | +$3.85K |
|
2555
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
$1.22B
| $1.35M | ﹤0.01% |
+12,500
| New | +$1.3M |
|
2556
MIND Technology
MIND
$43.4M
| $1.34M | ﹤0.01% |
33,982
+2,212
| +7% | +$84.8K |
|
2557
Consumer Portfolio Services
CPSS
$209M
| $1.34M | ﹤0.01% |
352,909
+26,302
| +8% | +$93.5K |
|
|
LORL
2558
DELISTED
Loral Space and Communications, Inc.
LORL
| $1.34M | ﹤0.01% |
38,769
+17,769
| +85% | +$643K |
|
|
BFX
2559
DELISTED
BowFlex Inc.
BFX
| $1.33M | ﹤0.01% |
+604,200
| New | +$2.38M |
|
|
CSS
2560
DELISTED
CSS Industries, Inc.
CSS
| $1.33M | ﹤0.01% |
272,019
+36,349
| +15% | +$212K |
|
|
FRTX
2561
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $1.32M | ﹤0.01% |
4,945
-129
| -3% | -$43.2K |
|
2562
Gentherm
THRM
$1.32B
| $1.32M | ﹤0.01% |
31,564
+19,064
| +153% | +$767K |
|
2563
Princeton Bancorp
BPRN
$283M
| $1.31M | ﹤0.01% |
43,623
+8,019
| +23% | +$238K |
|
2564
Denali Therapeutics
DNLI
$3.79B
| $1.31M | ﹤0.01% |
+63,000
| New | +$1.41M |
|
|
SEM
2565
DELISTED
Select Medical
SEM
| $1.3M | ﹤0.01% |
152,563
-160,730
| -51% | -$1.27M |
|
|
BOCH
2566
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $1.3M | ﹤0.01% |
122,100
-10,400
| -8% | -$111K |
|
2567
First US Bancshares
FUSB
$91.9M
| $1.3M | ﹤0.01% |
140,664
+10,320
| +8% | +$100K |
|
2568
Tennant Co
TNC
$1.44B
| $1.3M | ﹤0.01% |
21,200
-2,700
| -11% | -$168K |
|
|
SRRA
2569
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.29M | ﹤0.01% |
57,816
+10,433
| +22% | +$505K |
|
2570
PennyMac Financial
PFSI
$4.47B
| $1.29M | ﹤0.01% |
58,100
-10,245
| -15% | -$228K |
|
|
HUSN
2571
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
| $1.29M | ﹤0.01% |
282,785
+28,511
| +11% | +$153K |
|
2572
Neurocrine Biosciences
NBIX
$18.2B
| $1.29M | ﹤0.01% |
15,241
-212,700
| -93% | -$17.5M |
|
|
PBFX
2573
DELISTED
PBF LOGISTICS LP
PBFX
| $1.28M | ﹤0.01% |
60,600
+9,100
| +18% | +$188K |
|
2574
W.R. Berkley
WRB
$28.1B
| $1.28M | ﹤0.01% |
43,538
-1,337,512
| -97% | -$36.6M |
|
|
LOMA
2575
Loma Negra
LOMA
$1.34B
| $1.27M | ﹤0.01% |
108,612
+78,912
| +266% | +$831K |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.